Healthcare Equipment and Supplies
Company Overview of Globus Medical, Inc.
Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. It offers products that address an array of spinal pathologies, anatomies, and surgical approaches. The company provides fusion products that are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. It also offers disruptive technology products that provide material improvements to fusion procedures, such as minimally invasive surgical techniques, as well as new treatment alternatives, which include motion preser...
2560 General Armistead Avenue
Audubon, PA 19403
Founded in 2003
Key Executives for Globus Medical, Inc.
Co-Founder, Chairman, Chief Executive Officer, Chairman of Compensation Committee and Chairman of Nominating & Corporate Governance Committee
Total Annual Compensation: $405.3K
Co-Founder, Senior Vice President of Operations and Director
Total Annual Compensation: $234.7K
Group President of Emerging Technologies, Director and Member of Nominating and Corporate Governance Committee
Total Annual Compensation: $337.8K
Group President of Commercial Operations
Total Annual Compensation: $309.3K
Compensation as of Fiscal Year 2014.
Globus Medical, Inc. Key Developments
Globus Medical, Inc. Announces Preliminary Unaudited Sales Guidance for the Fourth Quarter and Full Year Ending December 31, 2015; Provides Earnings Guidance for the Full Year of 2016
Jan 6 16
Globus Medical, Inc. announced preliminary unaudited sales guidance for the fourth quarter and full year ending December 31, 2015. The company anticipates fourth quarter 2015 sales of approximately $142.6 million, growing 10.7% as reported or 11.5% in constant currency against fourth quarter 2014.
Full year 2015 estimated sales are expected to be approximately $544.7 million, growing 14.8% as reported or 16.0% in constant currency against the prior year, exceeding the company's previous guidance of $539 million.
The company established full year 2016 guidance of $583 million in sales and fully diluted earnings per share of $1.20. 2016 EPS guidance reflects an increase in net income in line with the expected sales growth, as well as a positive contribution from the recently-announced suspension of the Medical Device Tax. The full impact of the suspended Medical Device Tax is expected to be about $0.06 per share. 2016 guidance reflects approximately 7% growth in sales and 10% growth in EPS over the expected 2015 results.
Globus Medical, Inc. Presents at JPMorgan 34th Annual Healthcare Conference, Jan-14-2016 07:30 AM
Jan 5 16
Globus Medical, Inc. Presents at JPMorgan 34th Annual Healthcare Conference, Jan-14-2016 07:30 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, California, United States. Speakers: Anthony L. Williams, President, Daniel T. Scavilla, Chief Financial Officer and Senior Vice President, David C. Paul, Co-Founder, Chairman, Chief Executive Officer, Chairman of Compensation Committee and Chairman of Nominating & Corporate Governance Committee.
Globus Medical, Inc. Approves Amendment to Bylaws
Dec 10 15
On December 9, 2015, the board of directors of Globus Medical, Inc. approved an amendment to the bylaws of the Company, which became effective immediately. The Bylaw Amendment added a new section 8.13 to the bylaws which provides that unless the Company consents in writing to the selection of an alternative forum, the sole and exclusive forum for certain legal action involving the Company will be the Delaware Chancery Court, or the federal district court for the District of Delaware in the event the Delaware Chancery Court does not have jurisdiction. Unless the corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director or officer or other employee of the corporation to the corporation or the corporation's stockholders, (iii) any action asserting a claim against the corporation or any director or officer or other employee of the corporation arising pursuant to any provision of the General Corporation Law of Delaware or the certificate of incorporation or these bylaws (as either may be amended from time to time), and (iv) any action asserting a claim against the corporation or any director or officer or other employee of the corporation governed by the internal affairs doctrine, in each case, shall be the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, the federal district court for the District of Delaware). Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the corporation shall be deemed to have notice of and consented to the provisions of this Section.
Similar Private Companies By Industry
Recent Private Companies Transactions